4.6 Article

Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 Profiles in Patients with Relapsing-Remitting Multiple Sclerosis: Impact on Disease Activity and Progression

Related references

Note: Only part of the references are listed.
Article Neurosciences

Diagnostic and prognostic value of the RUNXOR/RUNX1 axis in multiple sclerosis

San F. A. Haridy et al.

Summary: This study investigates the role of RUNX1 and its lncRNA RUNXOR in the development and progression of multiple sclerosis (MS) and explores their mechanism of action. The expression levels of RUNXOR, RUNX1, MAP2, NGF, BDNF and IL-10 were significantly decreased in MS patients compared to healthy controls. Furthermore, RUNXOR, RUNX1 mRNA, and its protein levels were identified as predictors of disease progression and RUNX1 mRNA exhibited diagnostic potential. These findings suggest the involvement of the RUNXOR-RUNX1 axis in MS development and highlight the potential utility of these parameters as diagnostic/prognostic biomarkers for MS.

NEUROBIOLOGY OF DISEASE (2023)

Article Biochemistry & Molecular Biology

Regulatory Cells in Multiple Sclerosis: From Blood to Brain

Leticia Calahorra et al.

Summary: Multiple sclerosis (MS) is a chronic, autoimmune, and neurodegenerative disease of the central nervous system (CNS) characterized by the demyelination of nerve fibers. While T cells were traditionally thought to be the key players in MS pathogenesis, recent research has highlighted the significant roles of B lymphocytes and innate immune cells. Protective regulatory cells, such as myeloid-derived suppressor cells and regulatory T and B cells, are increasingly recognized for their potential in therapy development for MS.

BIOMEDICINES (2022)

Review Clinical Neurology

The role of inflammasomes in multiple sclerosis

Hanie Yavarpour-Bali et al.

Summary: Multiple sclerosis is an inflammatory autoimmune disease of the central nervous system, with current therapies mainly focusing on immunosuppressive drugs. Inflammasomes play a critical role in the development of MS, and studying the effects of inflammasome inhibitor drugs is important for understanding and treating the disease.

MULTIPLE SCLEROSIS JOURNAL (2021)

Review Biochemistry & Molecular Biology

LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides

Marco Bocchetti et al.

Summary: lncRNAs play a crucial role in regulating gene transcription during inflammatory responses, and recent studies have shown their dysregulation in human diseases is linked to immune mechanisms, offering insights into resolving complex disease relationships.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Pharmacology & Pharmacy

Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis

Shuai Shao et al.

Summary: Inflammasomes are multi-protein complexes that regulate the maturation and secretion of IL-1 beta and IL-18 in response to PAMPs or DAMPs in host cells. The NLRP3 inflammasome is well-understood in molecular mechanisms, serving as a promising therapeutic target in immune-related disorders such as multiple sclerosis (MS). Investigation of NLRP3 activation mechanisms in MS and experimental models may lead to new therapeutic strategies for the disease.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Neurosciences

The Expanding Regulatory Mechanisms and Cellular Functions of Long Non-coding RNAs (lncRNAs) in Neuroinflammation

Shraddha Tripathi et al.

Summary: Long non-coding RNAs (lncRNAs) have emerged as important regulators in biological processes, interacting with proteins, RNA, and DNA to regulate gene expression pathways. Altered lncRNA expression in CNS diseases contributes to regulating both pro-inflammatory and anti-inflammatory pathways. The review discusses molecular pathways, mechanisms, and therapeutic potential of lncRNAs in CNS disorders related to neuroinflammation.

MOLECULAR NEUROBIOLOGY (2021)

Article Immunology

Long Non-Coding RNA- Associated Competing Endogenous RNA Axes in T-Cells in Multiple Sclerosis

Hani Sabaie et al.

Summary: This study aimed to clarify the molecular regulatory mechanisms involved in T-cells responses in MS by exploring the lncRNA-associated ceRNA axes. The research identified a ceRNA regulatory relationship among SNHG1, hsa-miR-197-3p, YOD1, ZNF101 and downstream connected genes, potentially playing a role in the pathogenesis of MS. Pathway enrichment analysis showed that differentially expressed mRNAs were enriched in Protein processing in endoplasmic reticulum and Herpes simplex virus 1 infection pathways.

FRONTIERS IN IMMUNOLOGY (2021)

Review Genetics & Heredity

Non-coding RNAs in the Pathogenesis of Multiple Sclerosis

Aadil Yousuf et al.

Summary: Multiple sclerosis (MS) is a chronic neurological condition characterized by inflammation, demyelination, gliosis, and axonal loss. The disease's complex pathological cause involves genetic and environmental factors. Studies have revealed the significant role of non-protein-coding RNAs (ncRNAs) like miRNAs and lncRNAs in MS pathogenesis, providing insights for diagnosis and treatment.

FRONTIERS IN GENETICS (2021)

Article Neurosciences

Circulating lncRNAs HIF1A-AS2 and LINLK-A: Role and Relation to Hypoxia-Inducible Factor-1α in Cerebral Stroke Patients

Heba A. Ewida et al.

Summary: Long noncoding RNAs play a critical role in cerebral gene expression, with the study identifying changes in lncRNAs and target gene expression related to stroke, as well as significant alterations in serum markers.

MOLECULAR NEUROBIOLOGY (2021)

Article Endocrinology & Metabolism

Long Noncoding RNA SNHG1 Promotes Lipopolysaccharide-Induced Activation and Inflammation in Microglia via Targeting miR-181b

Jun Dong et al.

Summary: SNHG1 is involved in LPS-induced microglial activation and inflammation response by targeting miR-181b, providing further evidence of its roles in neuroinflammation.

NEUROIMMUNOMODULATION (2021)

Review Medicine, General & Internal

Treatment of Multiple Sclerosis: A Review

Stephen L. Hauser et al.

AMERICAN JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation

Zhenyi Xue et al.

CELL DEATH AND DIFFERENTIATION (2019)

Review Medicine, Research & Experimental

Inflammasomes in neuroinflammatory and neurodegenerative diseases

Sofie Voet et al.

EMBO MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Knockdown of lncRNA SNHG1 attenuated Aβ25-35 -inudced neuronal injury via regulating KREMEN1 by acting as a ceRNA of miR-137 in neuronal cells

Hui Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

NLRP3 negatively regulates Treg differentiation through Kpna2-mediated nuclear translocation

Su-Ho Park et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Clinical Neurology

Multiple sclerosis - a review

R. Dobson et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Article Clinical Neurology

Inflammasome Proteins As Biomarkers of Multiple Sclerosis

Robert W. Keane et al.

FRONTIERS IN NEUROLOGY (2018)

Review Biochemistry & Molecular Biology

Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses

Nicholas W. Mathy et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Review Immunology

TGF- regulation of encephalitogenic and regulatory T cells in multiple sclerosis

Priscilla W. Lee et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2017)

Article Pediatrics

Characteristics of Children and Adolescents With Multiple Sclerosis

Anita L. Belman et al.

PEDIATRICS (2016)

Review Immunology

FOXP3+ regulatory T cells and their functional regulation

Zhiyuan Li et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2015)

Review Public, Environmental & Occupational Health

Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review

Tomas Kalincik

NEUROEPIDEMIOLOGY (2015)

Review Immunology

Regulatory T cells in autoimmune neuroinflammation

Markus Kleinewietfeld et al.

IMMUNOLOGICAL REVIEWS (2014)

Article Immunology

Protein kinase C-η controls CTLA-4-mediated regulatory T cell function

Kok-Fai Kong et al.

NATURE IMMUNOLOGY (2014)

Review Clinical Neurology

Defining the clinical course of multiple sclerosis The 2013 revisions

Fred D. Lublin et al.

NEUROLOGY (2014)

Article Multidisciplinary Sciences

A Long Noncoding RNA Mediates Both Activation and Repression of Immune Response Genes

Susan Carpenter et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis

Makoto Inoue et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Clinical Neurology

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria

Chris H. Polman et al.

ANNALS OF NEUROLOGY (2011)

Review Clinical Neurology

The role of regulatory T cells in multiple sclerosis

Alla L. Zozulya et al.

NATURE CLINICAL PRACTICE NEUROLOGY (2008)